Compare iShares MSCI Malaysia ETF (EWM) vs GSK plc (GSK) Price & Performance

EWM, the iShares MSCI Malaysia ETF, trades at $28.28, up 0.86% today, with a bearish technical signal from moving averages and oscillators neutral. The ETF is heavily weighted in Financials (54%) and Industrials (21%). Recent news highlights Malaysia's data center expansion, semiconductor ambitions, and tourism initiatives as growth drivers, though the country faces energy supply challenges amid rising power demand.

Outlook is mixed: Malaysia's economic initiatives offer potential upside, but energy constraints and concentrated sector exposure pose risks. The ETF provides targeted emerging market access, with investor sentiment cautious due to macroeconomic uncertainties and technical weakness.

GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.

The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.